The Recall Desk

Manufacturer

Viiv Healthcare Company

1 recall in our database name Viiv Healthcare Company as the manufacturing or recalling firm.

What the numbers show

Total
1
Critical
0
Severe
0
Most recent
2014-04-09

Of the 1 recalls from Viiv Healthcare Company we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–1 of 1

  • ModerateFDA (Drugs)·D-1185-2014·2014-04-09

    Viiv Healthcare Recalls Tivicay Tablets Due to Cross-Contamination with Promacta

    Viiv Healthcare is recalling 1,056 bottles of Tivicay (dolutegravir) 50 mg tablets because they were found to contain Promacta (eltrombopag). The recall covers products distributed nationwide, including Puerto Rico.

    Product
    TIVICAY — TIVICAY (DOLUTEGRAVIR SODIUM)
    Category
    Drug
    Distribution
    Distributed nationwide